SCHEMBL21068043

SCHEMBL21068043

COc1cc(CS(C)(=O)=O)ccc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGF1R P08069 20/20 0.66
▸ MAPK8 P45983 17/20 0.66
▸ MAPK10 P53779 2/20 0.65
▸ ALK Q9UM73 2/20 0.65
▸ INSR P06213 1/20 0.65
▸ CDC7 O00311 1/20 0.59
▸ PLK4 O00444 1/20 0.59
▸ CHEK1 O14757 1/20 0.59
▸ DAPK3 O43293 1/20 0.59
▸ PRKD3 O94806 1/20 0.59
▸ PRKCG P05129 1/20 0.59
▸ ROS1 P08922 1/20 0.59
▸ PIM1 P11309 1/20 0.59
▸ FER P16591 1/20 0.59
▸ LTK P29376 1/20 0.59
▸ AXL P30530 1/20 0.59
▸ GRK5 P34947 1/20 0.59
▸ MAPK9 P45984 1/20 0.59
▸ CSNK1A1 P48729 1/20 0.59
▸ CLK2 P49760 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29395565 1.00 IGF1R (0.66) IGF1RMAPK8MAPK10ALKINSR
SCHEMBL12429391 0.87 GRK5 (0.73) IGF1RGRK5PTK2
SCHEMBL12430015 0.82 IGF1R (0.81) IGF1RMAPK8MAPK10ALKINSR
SCHEMBL12429328 0.82 GRK5 (0.69) IGF1RMAPK8GRK5
SCHEMBL12429667 0.80 IGF1R (0.70) IGF1RMAPK8MAPK10ALKINSR
SCHEMBL12430019 0.80 IGF1R (0.77) IGF1RMAPK8MAPK10ALKINSR
SCHEMBL12429698 0.79 IGF1R (0.69) IGF1RMAPK8MAPK10ALKINSR
SCHEMBL12429671 0.79 IGF1R (0.75) IGF1RMAPK8MAPK10ALKINSR
SCHEMBL12429443 0.79 IGF1R (0.77) IGF1RMAPK8MAPK10ALKINSR
SCHEMBL11919217 0.79 IGF1R (1.00) IGF1RMAPK8MAPK10ALKINSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210254056-A1 IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS CAMP4 THERAPEUTICS CORPORATION 2021-08-19 — — US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 — — US disclosed
Send feedback